300
Participants
Start Date
August 27, 2025
Primary Completion Date
October 31, 2026
Study Completion Date
January 31, 2028
NT 201
Clostridium Botulinum neurotoxin A (150 kiloDalton \[kD\], free of complexing proteins), powder for solution for injection.
NT 201 Placebo
NT 201 matching-placebo
RECRUITING
Merz Investigative Site, New York
RECRUITING
Merz Investigative Site, New York
RECRUITING
Merz Investigative Site, Mount Kisco
RECRUITING
Merz Investigative Site, Ardmore
RECRUITING
Merz Investigative Site, Washington D.C.
RECRUITING
Merz Investigative Site, Hunt Valley
RECRUITING
Merz Investigative Site, Arlington
RECRUITING
Merz Investigative Site, Chapel Hill
RECRUITING
Merz Investigative Site, Wilmington
RECRUITING
Merz Investigative Site, Alpharetta
RECRUITING
Merz Investigative Site, Coral Gables
RECRUITING
Merz Investigative Site, Coral Gables
RECRUITING
Merz Investigative Site, Aventura
RECRUITING
Merz Investigative Site, West Palm Beach
RECRUITING
Merz Investigative Site, Boca Raton
RECRUITING
Merz Investigative Site, Bradenton
RECRUITING
Merz Investigative Site, Nashville
RECRUITING
Merz Investigative Site, Naperville
RECRUITING
Merz Investigative Site, Dallas
RECRUITING
Merz Investigative Site, Greenwood Village
RECRUITING
Merz Investigative Site, Scottsdale
RECRUITING
Merz Investigative Site, Redondo Beach
RECRUITING
Merz Investigative Site, Santa Monica
RECRUITING
Merz Investigative Site, Encino
RECRUITING
Merz Investigative Site, Vista
RECRUITING
Merz Investigative Site, San Juan
Merz North America, Inc.
INDUSTRY